Cell Intrinsic IL-38 Affects B Cell Differentiation and Antibody Production
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065676 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Arnaud Huard und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany. Hauptthemen laut MEDLINE: Antibody Formation, B-Lymphocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
IL-38 is an IL-1 family receptor antagonist with an emerging role in chronic inflammatory diseases. IL-38 expression has been mainly observed not only in epithelia, but also in cells of the immune system, including macrophages and B cells. Given the association of both IL-38 and B cells with chronic inflammation, we explored if IL-38 affects B cell biology. IL-38-deficient mice showed higher amounts of plasma cells (PC) in lymphoid organs but, conversely, lower levels of plasmatic antibody titers. Exploring underlying mechanisms in human B cells revealed that exogenously added IL-38 did not significantly affect early B cell activation or differentiation into plasma cells, even though IL-38 suppressed upregulation of CD38. Instead, IL-38 mRNA expression was transiently upregulated during the differentiation of human B cells to plasma cells in vitro, and knocking down IL-38 during early B cell differentiation increased plasma cell generation, while reducing antibody production, thus reproducing the murine phenotype. Although this endogenous role of IL-38 in B cell differentiation and antibody production did not align with an immunosuppressive function, autoantibody production induced in mice by repeated IL-18 injections was enhanced in an IL-38-deficient background. Taken together, our data suggest that cell-intrinsic IL-38 promotes antibody production at baseline but suppresses the production of autoantibodies in an inflammatory context, which may partially explain its protective role during chronic inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany.
- Division of Rheumatology, Department of Medicine, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
- Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
- Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Göttingen, 37075 Göttingen, Germany.
- Geneva Center for Inflammation Research, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, 60596 Frankfurt, Germany.
ORCID-Profile: Arnaud Huard, Gaby Palmer, Bernhard Brüne, Andreas Weigert
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Huard, A., Wilmes, C., Kiprina, A., Netzer, C., Palmer, G., Brüne, B., & Weigert, A. (2023). Cell Intrinsic IL-38 Affects B Cell Differentiation and Antibody Production. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065676
Vancouver
Huard A, Wilmes C, Kiprina A, Netzer C, Palmer G, Brüne B, et al. Cell Intrinsic IL-38 Affects B Cell Differentiation and Antibody Production. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065676
BibTeX
@article{Huard2023,
author = {Huard, Arnaud and Wilmes, Christian and Kiprina, Anastasiia and Netzer, Christoph and Palmer, Gaby and Brüne, Bernhard and Weigert, Andreas},
title = {Cell Intrinsic IL-38 Affects B Cell Differentiation and Antibody Production},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065676}
}
EUVIMED